Stay updated on Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial
Sign up to get notified when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.

Latest updates to the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedLocations section consolidated into a single multi-state/cross-border list of study sites (CA, FL, GA, IL, MD, MA, MN, MO, NY, TN, TX, WA, Ontario) with revision 3.3.3.SummaryDifference1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedRevision: v3.3.2 is displayed; no changes to core study content such as eligibility criteria, endpoints, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded publication notes clarifying that results publications are provided voluntarily and auto-filled from PubMed, and updated the revision to v3.3.1; older phrasing and the v3.2.0 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedA generic government funding status notice has been removed from the page. The study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check67 days agoChange DetectedThe changes shown in the screenshots are minor UI/layout updates with no changes to core content such as the study title, interventions, outcomes, eligibility criteria, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check96 days agoChange DetectedAdded a government funding lapse notice and updated version to v3.2.0; removed the old v3.1.0 version tag. The page now communicates current operating status and directs users to official sources for updates.SummaryDifference1%

Stay in the know with updates to Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.